The following data is part of a premarket notification filed by American Healthcare Inc. with the FDA for Blood Glucose Monitoring System.
| Device ID | K043543 |
| 510k Number | K043543 |
| Device Name: | BLOOD GLUCOSE MONITORING SYSTEM |
| Classification | System, Test, Blood Glucose, Over The Counter |
| Applicant | AMERICAN HEALTHCARE INC. 304 PARK AVENUE SOUTH SUITE 218 New York, NY 10010 -4301 |
| Contact | Edward Letko |
| Correspondent | Edward Letko AMERICAN HEALTHCARE INC. 304 PARK AVENUE SOUTH SUITE 218 New York, NY 10010 -4301 |
| Product Code | NBW |
| CFR Regulation Number | 862.1345 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Traditional |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 2004-12-20 |
| Decision Date | 2005-04-08 |
| Summary: | summary |
| Device Identifier | submissionNumber | Supplement |
|---|---|---|
| 00885502001041 | K043543 | 000 |
| 00885502000044 | K043543 | 000 |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() BLOOD GLUCOSE MONITORING SYSTEM 98453047 not registered Live/Pending |
Shenzhen Wangzhi Technology Co., Ltd. 2024-03-16 |